NF11_1_Par_107_2_md5sums.txt

syn63386805

Created By Alyza Skaist askaist

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

NF11_1_Par_107_2_md5sums.txt page is loading…